(Q68225187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Immunomodulatory effects of ursodeoxycholic acid on immune responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

M Yoshikawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

T Tsujii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

K Matsumura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

J Yamao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Y Matsumura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R Kubo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

H Fukui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

S Ishizaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

English

0 references

publication date

1 August 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

358-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

Primary biliary cirrhosis

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Localisation of immunoglobulin on the liver cell surface in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Effects of bile acids on liver cell injury by cultured supernatant of activated liver adherents cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

The glomerular permeability determined by dextran clearance using Sephadex gel filtration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

A plaque assay for all cells secreting Ig of a given type or class

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

The functional relationship of the interleukins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Expression of MHC products by normal and abnormal bile duct epithelium

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Differential effect of interferon-gamma and interleukin-2 on the induction of IgA and IgM anti-dextran responses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Modulation of lymphocyte proliferation and immunoglobulin synthesis by interferon-gamma and "type I" interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

A functional dichotomy in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160213

7 January 2021

Identifiers

DOI

10.1002/HEP.1840160213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1639344%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference